These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 15220960)

  • 1. CD34-enriched peripheral stem cells infusion for graft insufficiency treatment in a pediatric patient with severe aplastic anemia after allogeneic bone marrow transplantation.
    Trakhtman P; Shipicina I; Balashov D; Scvortsova J; Dishlevaja Z; Blagonravova O; Maschan A
    Bone Marrow Transplant; 2004 Sep; 34(5):465-6. PubMed ID: 15220960
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined transplantation of G-CSF primed allogeneic bone marrow cells and peripheral blood stem cells in treatment of severe aplastic anemia.
    Huang XJ; Chen YH; Xu LP; Zhang YC; Liu DH; Guo NL; Lu DP
    Chin Med J (Engl); 2004 Apr; 117(4):604-7. PubMed ID: 15109458
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hematopoietic stem-cell transplantation in aplastic anemia].
    Hernández-Rivera EG
    Rev Invest Clin; 2005; 57(2):298-304. PubMed ID: 16524071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukaemic transformation of donor cells in a patient receiving a second allogeneic bone marrow transplant for severe aplastic anaemia.
    Lawler M; Locasciulli A; Longoni D; Schiro R; McCann SR
    Bone Marrow Transplant; 2002 Mar; 29(5):453-6. PubMed ID: 11919737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor leukocyte infusion for late graft failure in a patient with severe aplastic anemia after allogeneic bone marrow transplantation.
    Hashino S; Kondo T; Yonezumi M; Chiba K; Tsutsumi Y; Kondo Y; Tanaka J; Imamura M; Asaka M
    Bone Marrow Transplant; 2004 Jan; 33(1):133-4. PubMed ID: 14578931
    [No Abstract]   [Full Text] [Related]  

  • 6. Aetiology of severe aplastic anaemia and outcome after allogeneic bone marrow transplantation or immunosuppression therapy. Working Party on Severe Aplastic Anaemia of the European Blood and Marrow Transplantation Group.
    Bacigalupo A
    Eur J Haematol Suppl; 1996; 60():16-9. PubMed ID: 8987236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Favorable outcome with allogeneic hematopoietic stem cell transplantation in pediatric acquired aplastic anemia patients.
    Unal S; Cetin M; Tavil B; Calişkan N; Yetgin S; Uçkan D
    Pediatr Transplant; 2007 Nov; 11(7):788-91. PubMed ID: 17910658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The treatment with allogeneic peripheral blood stem cell transplantation for benzene-induced severe aplastic anemia].
    Huang ZQ; Chen JY; Cao LX; Wu JM; Jiang CQ; Liu WW
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2003 Aug; 21(4):241-3. PubMed ID: 14761424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatitis following allogeneic bone marrow transplantation in a patient with aplastic anemia.
    Ikushima S; Hibi S; Todo S; Morimoto A; Sawada T; Tsunamoto K; Imashuku S
    Bone Marrow Transplant; 1996 Aug; 18(2):485-6. PubMed ID: 8864474
    [No Abstract]   [Full Text] [Related]  

  • 10. Cotransplantation of haploidentical mesenchymal stem cells to enhance engraftment of hematopoietic stem cells and to reduce the risk of graft failure in two children with severe aplastic anemia.
    Fang B; Li N; Song Y; Li J; Zhao RC; Ma Y
    Pediatr Transplant; 2009 Jun; 13(4):499-502. PubMed ID: 18673358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of posthepatitic severe aplastic anemia treated with allogeneic bone marrow transplantation (author's transl)].
    Yoshikawa S; Yamaguchi H; Naito K; Naoe T; Haga K; Morishima Y; Hirabayashi N; Watanabe E; Kodera Y; Kawasima K; Yamada K
    Rinsho Ketsueki; 1979 Nov; 20(11):1459-66. PubMed ID: 395332
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen.
    Inamoto Y; Suzuki R; Kuwatsuka Y; Yasuda T; Takahashi T; Tsujimura A; Sugimoto K; Oba T; Terakura S; Atsuta Y; Murata M; Ito M; Kodera Y; Miyamura K
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):43-9. PubMed ID: 18158960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case problems in bone marrow transplantation. I. Graft failure in aplastic anemia: its biology and treatment.
    Champlin RE; Feig SA; Gale RP
    Exp Hematol; 1984 Oct; 12(9):728-33. PubMed ID: 6386510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
    Kasow KA; Sims-Poston L; Eldridge P; Hale GA
    Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic peripheral blood stem cell transplantation as a second transplant for severe aplastic anemia.
    Gürman G; Kahveci G; Akan H I; Ilhan O; Koç H; Beksaç M; Konuk N; Uysal A
    Bone Marrow Transplant; 1995 Mar; 15(3):485-6. PubMed ID: 7599578
    [No Abstract]   [Full Text] [Related]  

  • 16. Fatal post-transplant lymphoproliferative disorder following allogeneic bone marrow transplantation for aplastic anemia.
    Rudzki Z; Werda L; Piatkowska-Jakubas B; Mensah P; Zazula M; Białas M; Skotnicki AB; Stachura J
    Pol J Pathol; 2002; 53(1):35-40. PubMed ID: 12014224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of cyclosporin alone, or cyclosporin and methotrexate, on the incidence of mixed haematopoietic chimaerism following allogeneic sibling bone marrow transplantation for severe aplastic anaemia.
    McCann S; Passweg J; Bacigalupo A; Locasciulli A; Locatelli F; Ryan J; Schrezenmeier H; Lawler M
    Bone Marrow Transplant; 2007 Jan; 39(2):109-14. PubMed ID: 17173053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haploidentical stem cell transplantation with purified CD34+ cells after a chemotherapy-alone conditioning regimen in heavily transfused severe aplastic anemia.
    Lacerda JF; Martins C; Carmo JA; Lourenço F; Juncal C; Ismail S; Lacerda JM
    Biol Blood Marrow Transplant; 2005 May; 11(5):399-400. PubMed ID: 15846294
    [No Abstract]   [Full Text] [Related]  

  • 19. Fludarabine, cyclophosphamide, anti-thymocyteglobulin, and low-dose total body irradiation conditioning enables 1-HLA-locus-mismatched hematopoietic stem cell transplantation for very severe aplastic anemia without affecting ovarian function.
    Okuda S; Terasako K; Oshima K; Sato M; Nakasone H; Kako S; Yamazaki R; Tanaka Y; Tanihara A; Higuchi T; Nishida J; Kanda Y
    Am J Hematol; 2009 Mar; 84(3):167-9. PubMed ID: 19195036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Etiopathogenesis of aplastic anemia and of the severe form treated with immunosuppression and bone marrow transplantation].
    Dulley FL; Lotério HA; Massumoto CM; Llacer PE; Chamone Dde A
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(4):167-70. PubMed ID: 2696069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.